Generali Investments CEE’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.59M Hold
107,648
– – 0.12% 178
2026
Q1
$3.02M Hold
107,648
– – 0.16% 168
2025
Q4
$2.68M Sell
107,648
-1,621
-1% -$40.9K 0.19% 162
2025
Q3
$2.78M Buy
109,269
+47,319
+76% +$1.17M 0.21% 134
2025
Q2
$1.5M Hold
61,950
– – 0.12% 194
2025
Q1
$1.57M Sell
61,950
-30,200
-33% -$790K 0.15% 183
2024
Q4
$2.44M Buy
+92,150
New +$2.5M 0.25% 122

Other funds holding PFE

Generali Investments CEE's PFE Position: Q2 2026 in Review

Generali Investments CEE held its Pfizer (PFE) position steady in Q2 2026 at 107,648 shares worth $2.59M. The position accounts for 0.12% of the portfolio, ranked #178.

Generali Investments CEE first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.02M in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Generali Investments CEE held 107,648 shares of Pfizer worth $2.59M as of Q2 2026.
  • Generali Investments CEE left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.12% of Generali Investments CEE's portfolio in Q2 2026, its #178 holding.
  • Generali Investments CEE first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments CEE's Pfizer position peaked at $3.02M in Q1 2026.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.